MedTrace Logo

Sperm Selection Using Microfluidic Technology

NCT04997070 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1038

Last updated 2024-03-06

No results posted yet for this study

Summary

This clinical study has been organised to investigate whether microfluidic technology may be considered as a new procedure for routine sperm preparation during assisted reproduction. This is a technique that is already used in other centres.

The Microfluidic Sperm Sorting (MSS) technology reduces the time of sample preparation while selects a sperm population with better motility and less DNA fragmentation as compared to routine procedures. This med-ical device is already CE marked.

Having the intention to implement this technology in our department, we conduct this study to investigate whether the use of MSS has at least the same impact, if not better, on fertilization and embryo quality as compared to standard sperm selection procedures.

Conditions

  • Infertility, Male

Sponsors & Collaborators

  • CRG UZ Brussel

    lead OTHER

Principal Investigators

  • Koen Wouters, Msc · Brussels IVF

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-16
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04997070 on ClinicalTrials.gov